日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Effectiveness of ICI-ICI versus ICI-TKI combinations in patients with IMDC intermediate- and poor-risk metastatic renal cell carcinoma: a sub-analysis of the MEET-URO 33 study

在IMDC中危和高危转移性肾细胞癌患者中,ICI-ICI联合方案与ICI-TKI联合方案的疗效比较:MEET-URO 33研究的亚组分析

Maffezzoli, Michele; Signori, Alessio; Acunzo, Alessandro; Buti, Sebastiano; Bosoni, Michela; Verzoni, Elena; Di Marco, Andrea; Lolli, Cristian; Di Napoli, Marilena; Fanelli, Martina; Volta, Alberto Dalla; Masini, Cristina; Roviello, Giandomenico; Iacovelli, Roberto; Mennitto, Alessia; Filippi, Roberto; Sorarù, Mariella; Formisano, Luigi; Guida, Annalisa; Fantinel, Emanuela; Messina, Carlo; Bonomi, Lucia; Scagliarini, Sarah; Nasso, Cecilia; Chiellino, Silvia; Maiorano, Brigida Anna; Deppieri, Filippo; Cavo, Alessia; Conteduca, Vincenza; Zai, Silvia; Zucali, Paolo Andrea; Tucci, Marcello; Vignani, Francesca; La Russa, Francesca; Lombardo, Laura; Caserta, Claudia; Paolieri, Federico; Bertolotti, Francesca; Rescigno, Pasquale; Banna, Giuseppe Luigi; Fornarini, Giuseppe; Bimbatti, Davide; Rebuzzi, Sara Elena

Site and number of metastases predict outcomes in avelumab maintenance for advanced UC: results from meet-URO 25

转移部位和数量可预测晚期尿路上皮癌患者接受阿维鲁单抗维持治疗的疗效:来自 meet-URO 25 的研究结果

Roviello, Giandomenico; Gambale, Elisabetta; De Gennaro Aquino, Irene; Maruzzo, Marco; Messina, Carlo; Vascotto, Ismaela Anna; Rossi, Virginia; Bimbatti, Davide; Erbetta, Elisa; Messina, Marco; Mennitto, Alessia; Rebuzzi, Sara Elena; Nasso, Cecilia; Mercinelli, Chiara; Catalano, Martina; Maiorano, Brigida Anna; Fanelli, Martina; Sorarù, Mariella; Scolari, Federico; Mela, Marinella Micol; Galli, Luca; Salfi, Alessia; Rizzo, Mimma; Puglisi, Silvia; Orlando, Valentina; Fornarini, Giuseppe; Rametta, Alessandro; Giannatempo, Patrizia; Cerbone, Linda; Doni, Laura; Pillozzi, Serena; Antonuzzo, Lorenzo

Long-Term Oncological Outcomes in Metastatic Prostate Cancer Patients Who Are Able to Maintain/Recover Ongoing Anticancer Therapy After SARS-CoV-2 Infection-Results of the MEET-URO 22 Study

SARS-CoV-2感染后能够维持/恢复抗癌治疗的转移性前列腺癌患者的长期肿瘤学预后——MEET-URO 22研究结果

Caffo, Orazio; Basso, Umberto; Veccia, Antonello; Maruzzo, Marco; Maiorano, Brigida Anna; Buttigliero, Consuelo; Mucciarini, Claudia; Mennitto, Alessia; Ermacora, Paola; Sorarù, Mariella; Vitale, Maria Giuseppa; Anesi, Cecilia; Kadrija, Dzenete; Maines, Francesca; Morelli, Franco; Romeo, Caterina; Bimbatti, Davide; Saporita, Isabella; Pierantoni, Francesco

Real-world effectiveness of Avelumab maintenance in advanced urothelial carcinoma: results from the Italian multicenter MALVA study (Meet-URO 25)

Avelumab维持治疗在晚期尿路上皮癌中的真实世界疗效:来自意大利多中心MALVA研究(Meet-URO 25)的结果

Roviello, Giandomenico; Gambale, Elisabetta; De Gennaro Aquino, Irene; Maruzzo, Marco; Messina, Carlo; Vascotto, Ismaela Anna; Rossi, Virginia; Bimbatti, Davide; Erbetta, Elisa; Messina, Marco; Mennitto, Alessia; Rebuzzi, Sara Elena; Nasso, Cecilia; Mercinelli, Chiara; Maiorano, Brigida Anna; Fanelli, Martina; Sorarù, Mariella; Scolari, Federico; Mela, Marinella Micol; Galli, Luca; Salfi, Alessia; Rizzo, Mimma; Puglisi, Silvia; Orlando, Valentina; Fornarini, Giuseppe; Rametta, Alessandro; Giannatempo, Patrizia; Cerbone, Linda; Doni, Laura; Pillozzi, Serena; Antonuzzo, Lorenzo

IUC24415-81 Clinical outcomes in stage I seminoma patients aged ≥ 45 years according to treatment modality

IUC24415-81 45岁及以上I期精原细胞瘤患者的临床结局(按治疗方式划分)

Kao, Grace S; Xu, Wenxin (Vincent); Xie, Wanling; Liu, Fuguo; Birch, Grace; Welch, Casey; Nguyen, Maily; Stanojevic, Mila; Viswanathan, Srinivas; McGregor, Bradley A; Ritz, Jerome; Braun, David; Nikiforow, Sarah; Romee, Rizwan; Choueri, Toni; Tang, Yan; Han, Tiegang; Mansour, Hadi; Hirsch, Michelle S; Collins, Katrina; Henske, Elizabeth P; Tang, Cerise; Poduval, Deepak; Rout, Rishabh; Lee, Suzanna; Panian, Justine; Saidian, Ava; McKay, Rana; Braun, David; Wilde, Blake; Christofk, Heather R; Bari, Shahla; Darwin, Alicia; Sarfraz, Humaira; Singh, Tarundeep; Muzaffar, Noha; Muzaffar, Jameel; Neola, G; Maruzzo, M; Maffezzoli, M; Rizzo, M; Scagliarini, S; Danielli, L; Conteduca, V; Giannatempo, P; Maiorano, B A; Formisano, L; Banna, G; Maniam, A; Rescigno, P; Reid, A; Crabb, S; Maffezzoli, M; Smalley, B; Redla, A C; Mehrotra, S; Tan, J K; Ghose, A; Shah, A; Kotecha, P; Sharma, A; Das, P; Teoh, J; Vasdev, N; Mascaro, F; Marmiroli, A; Nuzzo, A; Maruzzo, M; Bimbatti, D; Nazzani, S; Claps, M; Procopio, G; Nicolai, N; Giannatempo, P

IUC24428-85 Real-world effectiveness of ipilimumab plus nivolumab in second-line in patients with metastatic clear cell renal cell carcinoma (mccRCC) based on prior receipt of PD-1/L1 inhibitors

IUC24428-85 基于既往接受过 PD-1/L1 抑制剂治疗的转移性透明细胞肾细胞癌 (mccRCC) 患者二线治疗中,ipilimumab 联合 nivolumab 的真实世界疗效

Einarsdottir, Sigrun; Andersson, Per-Ola; Ayanambakkam, Adanma; McKay, Rana; Basu, Arnab; Maughan, Benjamin; Plets, Melissa; Pal, Sumanta; Ged, Yasser; Tangen, Cathryn; Vaishampayan, Ulka; Lerner, Seth; Desai, Arpita; Xie, Bingqing; Mishra, Akhilesh; Gao, Ming; Brugarolas, James; Rittenhouse, Nicole; Nargund Mangalvedhekar, Amrita; Zaidi, Samir; Hakimi, A Ari; Dere, Ruhee; Motrapu, Manga; Boice, Ashley; Han, Richard; Wang, Xiaoli; Chowdhury, Pratim; Jung, Sung; Prasad, B V Venkata; McGregor, Bradley A; Murgic, J; Jazvic, M; Tomaskovic, I; Bokarica, P; Gamulin, M; Dilber, I; Penc, M Sambic; Zahirovic, D; Omrcen, T; Frobe, A; Bimbatti, D; Messina, C; Bonomi, L; Scagliarini, S; Chiellino, S; Maiorano, B A; Deppieri, F M; Cavo, A; Conteduca, V; Rebuzzi, S E; Rebuzzi, S E; Messina, C; Bonomi, L; Scagliarini, S; Chiellino, S; Maiorano, B A; Deppieri, F M; Cavo, A; Conteduca, V; Bimbatti, D; Richert, Julia; Wenta, Robert; Muchlińska, Anna; Pieczyńska-Uziębło, Beata; Żaczek, Anna; Miszewski, Kevin; Matuszewski, Marcin; Bednarz-Knoll, Natalia; Ozay, Z I; Jo, Y; Ostrowski, M; Sayegh, N; Graf, R; Roy, S; Antonarakis, E; McKay, R; Agarwal, N; Swami, U; Maffezzoli, M; Pedapati, L; Hassan, M; Sandulache, S A; Samuel, J; Costanzo, F Di; Neola, G; Lau, J; Maniam, A; Banna, G; Mehrotra, S; Redla, A C; Tan, J K; Ghose, A; Maniam, A; Boussios, S; Banna, G L; Das, P; Adeleke, S; Sharma, A; Aggarwal, P; Satapathy, S; Sood, A; Goyal, S; Prakash, G; Mittal, B R; Ozay, Z I; Jo, Y; Gebrael, G; Ostrowski, M; Murdock, E; Jamie-Casas, S; Zugman, M; Agarwal, N; Pal, S; Swami, U

Prognostic Value of G8 Geriatric Screening and Meet-URO Scores in Metastatic Renal Cell Carcinoma Patients Receiving First-Line Ipilimumab-Nivolumab Combination Immunotherapy

G8老年筛查和Meet-URO评分在接受一线伊匹木单抗-纳武单抗联合免疫治疗的转移性肾细胞癌患者中的预后价值

Nagpal, Ria; Campione, Marina; Rebuzzi, Sara Elena; Fratino, Lucia; Rescigno, Pasquale; Bracarda, Sergio; Bimbatti, Davide; De Giorgi, Ugo; Santoni, Matteo; Calabrò, Fabio; Rizzo, Mimma; Signori, Alessio; Giannarelli, Diana; Fornarini, Giuseppe; Basso, Umberto; Banna, Giuseppe Luigi

Prognostic factors of long-term response to androgen receptor signaling inhibitors used as first-line treatment for mCRPC

一线治疗转移性去势抵抗性前列腺癌(mCRPC)的雄激素受体信号通路抑制剂长期疗效的预后因素

Veccia, Antonello; Basso, Umberto; Cattrini, Carlo; Ermacora, Paola; Maruzzo, Marco; Alberti, Martina; Anesi, Cecilia; Bimbatti, Davide; Cani, Massimiliano; Crespi, Veronica; Farinea, Giovanni; Kadrija, Dzenete; Kinspergher, Stefania; Lai, Eleonora; Lay, Ludovica; Maines, Francesca; Mennitto, Alessia; Pierantoni, Francesco; Samuelly, Alessandro; Urban, Susanna; Caffo, Orazio; Buttigliero, Consuelo

Role of Hb to RDW ratio in metastatic renal cell carcinoma patients treated with first-line immunotherapy combinations

血红蛋白/红细胞分布宽度比值在接受一线免疫疗法联合治疗的转移性肾细胞癌患者中的作用

Corianò, Matilde; Lazzarin, Alessandro; Maffezzoli, Michele; Santoni, Matteo; Mazzaschi, Giulia; Rodella, Sara; Simoni, Nicola; Lai, Eleonora; Maruzzo, Marco; Basso, Umberto; Bimbatti, Davide; Iacovelli, Roberto; Anghelone, Annunziato; Fiala, Ondřej; Rebuzzi, Sara Elena; Fornarini, Giuseppe; Lolli, Cristian; Massari, Francesco; Rosellini, Matteo; Mollica, Veronica; Nasso, Cecilia; Acunzo, Alessandro; Silini, Enrico Maria; Quaini, Federico; De Filippo, Massimo; Brunelli, Matteo; Banna, Giuseppe L; Rescigno, Pasquale; Signori, Alessio; Buti, Sebastiano

Meet-URO Score Validation in Real-world Patients with Metastatic Renal Cell Carcinoma Receiving First-line Pembrolizumab Plus axitinib: A Subanalysis of the Prospective ProPAXI Study

在接受一线帕博利珠单抗联合阿昔替尼治疗的转移性肾细胞癌患者中验证Meet-URO评分:前瞻性ProPAXI研究的亚组分析

Airò, Giulia; Guida, Annalisa; Gili, Alessio; Signori, Alessio; Rebuzzi, Sara Elena; Maruzzo, Marco; Lai, Eleonora; Pierantoni, Francesco; Bimbatti, Davide; Basso, Umberto; Damassi, Alessandra; Calabrò, Fabio; Cerbone, Linda; Caserta, Claudia; Sirgiovanni, Grazia; Serafin, Debora; Caffo, Orazio; Scagliarini, Sarah; Bracarda, Sergio; Buti, Sebastiano